Fortress Biotech FBIO
NASDAQ FBIO
$2.70 -0.03 (-0.92%)
As of: Sep 3, 2026 · 3:59 PM EDT

Fortress Biotech (FBIO) Short term Debt (2010 - 2021)

Fortress Biotech (FBIO) posted quarterly Short term Debt of $16000.0 for Q1 2019, down 87.1% year-over-year from $124000.0 in Q1 2018, and down 89.26% quarter-over-quarter from $149000.0 in Q4 2018.

Analysis

Fortress Biotech (FBIO) Short term Debt (2010 - 2021) Analysis & Trends

Fortress Biotech's Short term Debt history runs 3 years deep, the most recent figure standing at $16000.0 for Q1 2019.

  • In Q1 2019, Short term Debt fell 87.1% year-over-year to $16000.0; the TTM figure through Mar 2019 stood at $16000.0 (down 87.1% YoY), while the FY2018 annual figure was $149000.0, down 32.88% from the prior year.
  • Short term Debt for Q1 2019 stood at $16000.0, down from $149000.0 in the prior quarter.
  • The five-year high for Short term Debt was $623000.0 in Q1 2017, with the low at $16000.0 in Q1 2019.
  • The 3-year median for Short term Debt is $124000.0 (2018), against an average of $169555.6.
  • The sharpest annual moves came in 2018 and 2019: Short term Debt surged 73.86% in 2018, then tumbled 87.1% in 2019.
  • Fortress Biotech's Short term Debt stood at $222000.0 in 2017, then sank by 32.88% to $149000.0 in 2018, then plunged by 89.26% to $16000.0 in 2019.
  • Business Quant data shows FBIO's Short term Debt at $16000.0 in Q1 2019, $149000.0 in Q4 2018, and $153000.0 in Q3 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 141.52 Bn 133.66 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.69 Bn 78.69 Bn 3.93 Bn
3 Argenx Se 64.63 Bn 59.45 Bn 1.37 Bn
4 Moderna 59.30 Bn 54.16 Bn 52.00 Mn
5 Revolution Medicines 44.41 Bn 44.41 Bn -
6 BeOne Medicines 40.45 Bn 35.35 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.29 Bn 31.98 Bn 992.69 Mn
8 Royalty Pharma 28.44 Bn 27.60 Bn -
9 Insmed 27.55 Bn 26.39 Bn 358.27 Mn
10 Fortress Biotech 86.15 Mn -110.42 Mn 12.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2021 74,000.00
Sep 30, 2020 19,000.00
Mar 31, 2020 13,000.00
Dec 31, 2018 149,000.00
Sep 30, 2017 637,000.00
Jun 30, 2017 630,000.00
Mar 31, 2017 623,000.00
Dec 31, 2016 424,000.00
Sep 30, 2011 48,000.00
Dec 31, 2010 46,000.00